CoreAge Rx: Progesterone OralChecked 2026-09-27

Provider information

Open the original document ↗

Checked 2026-09-27. Records and commercial terms may change.

FDA: Prometrium prescribing information, revised February 2026Checked 2026-09-27

Prescribing information

Open the original document ↗

Checked 2026-09-27. Records and commercial terms may change.

DailyMed: Prometrium, Acertis Pharmaceuticals, updated July 23, 2026Checked 2026-09-27

Prescribing information

Open the original document ↗

Checked 2026-09-27. Records and commercial terms may change.

FDA: Understanding the risks of compounded drugsChecked 2026-09-27

Regulatory guidance

Open the original document ↗

Checked 2026-09-27. Records and commercial terms may change.

FDA: Hormone replacement therapies and current label changesChecked 2026-09-27

Regulatory guidance

Open the original document ↗

Checked 2026-09-27. Records and commercial terms may change.

Cost Plus Drugs: Progesterone 100 mg capsule listingChecked 2026-09-27

Pharmacy information

Open the original document ↗

Checked 2026-09-27. Records and commercial terms may change.

Cost Plus Drugs: Progesterone 200 mg capsule listingChecked 2026-09-27

Pharmacy information

Open the original document ↗

Checked 2026-09-27. Records and commercial terms may change.

Cost Plus Drugs: Contact your doctor and prescription workflowChecked 2026-09-27

Pharmacy information

Open the original document ↗

Checked 2026-09-27. Records and commercial terms may change.

Cost Plus Drugs: Information for prescribersChecked 2026-09-27

Pharmacy information

Open the original document ↗

Checked 2026-09-27. Records and commercial terms may change.

ACOG: Hormone therapy for menopauseChecked 2026-09-27

Clinical guidance

Open the original document ↗

Checked 2026-09-27. Records and commercial terms may change.

FDA: Generic drugs questions and answersChecked 2026-09-27

Regulatory guidance

Open the original document ↗

Checked 2026-09-27. Records and commercial terms may change.

FDA: First six menopausal hormone therapy label changes, February 12, 2026Checked 2026-10-21

Regulatory announcement

Open the original document ↗

Checked 2026-10-21. Records and commercial terms may change.

ACOG: Compounded Bioidentical Menopausal Hormone Therapy, November 2023Checked 2026-09-27

Medical society clinical consensus

Open the original document ↗

Checked 2026-09-27. Records and commercial terms may change.

FDA: Menopause and bioidentical hormone questionsChecked 2026-09-27

Federal regulator patient information

Open the original document ↗

Checked 2026-09-27. Records and commercial terms may change.

The Menopause Society: menopause glossaryChecked 2026-09-27

Medical society terminology

Open the original document ↗

Checked 2026-09-27. Records and commercial terms may change.

Pfizer: Provera medroxyprogesterone acetate tabletsChecked 2026-09-27

Exact product labeling

Open the original document ↗

Checked 2026-09-27. Records and commercial terms may change.

DailyMed: Endometrin progesterone vaginal insert, updated July 29, 2026Checked 2026-09-27

Exact product labeling

Open the original document ↗

Checked 2026-09-27. Records and commercial terms may change.

DailyMed: Crinone progesterone vaginal gel, updated May 21, 2024Checked 2026-09-27

Exact product labeling

Open the original document ↗

Checked 2026-09-27. Records and commercial terms may change.

British Menopause Society: Progestogens and endometrial protection, May 2026Checked 2026-09-27

UK medical society clinician guidance

Open the original document ↗

Checked 2026-09-27. Records and commercial terms may change.

FDA: Generic Drug FactsChecked 2026-09-27

Federal regulator approval explanation

Open the original document ↗

Checked 2026-09-27. Records and commercial terms may change.

FDA: Understanding Unapproved Use of Approved DrugsChecked 2026-09-27

Federal regulator explanation

Open the original document ↗

Checked 2026-09-27. Records and commercial terms may change.

Alloy: progesterone pill offerChecked 2026-10-13

Provider bioidentical/FDA-approved pill wording attributed; no supplied manufacturer or ingredient label confirmed, one-month price and three-month supply wording unresolved

Open the original document ↗

Checked 2026-10-13. Records and commercial terms may change.

DailyMed: Prometrium progesterone capsule label, updated July 23, 2026Checked 2026-09-29

Official structured label for the named oral product; chemical identity, micronization, formulation-specific ingredients and indications, not evidence of a reviewed provider supplying it

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

FDA: Generic Drug FactsChecked 2026-09-29

Federal generic-drug approval explanation; exact active ingredient, strength, dosage form, route and bioequivalence requirements, not a selected product or substitution instruction

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

Alloy: hormone replacement therapyChecked 2026-10-13

Provider clinical offer and one-time consultation fee; treatment categories not a personal recommendation

Open the original document ↗

Checked 2026-10-13. Records and commercial terms may change.

Alloy: terms of useChecked 2026-09-28

Dated platform terms; subscription and shipment cancellation deadlines, first-shipment refund conditions and service-fee exclusions kept separate

Open the original document ↗

Checked 2026-09-28. Records and commercial terms may change.

Midi Health: compounded oral micronized progesteroneChecked 2026-10-13

Provider exact product description with active and inactive ingredients; vegan and peanut-free wording attributed, not independent allergy clearance or FDA approval

Open the original document ↗

Checked 2026-10-13. Records and commercial terms may change.

FDA: Understanding the Risks of Compounded DrugsChecked 2026-09-29

Federal regulatory explanation; compounded preparations are not FDA-approved, no inference about inspection or quality of a named pharmacy

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

Midi: pricing and insuranceChecked 2026-10-13

Provider consultation units and self-pay prices; plan-dependent insurance and separate out-of-pocket medicine, no selected benefit verification

Open the original document ↗

Checked 2026-10-13. Records and commercial terms may change.

Midi: hormone replacement therapyChecked 2026-10-13

Provider care and access restrictions, including Medicaid/Medi-Cal and Medicare self-pay conditions; distinct from separate compounded capsule offer

Open the original document ↗

Checked 2026-10-13. Records and commercial terms may change.

Evernow: progesterone treatment serviceChecked 2026-09-29

Provider clinical service with progesterone benefit language; displayed FAQ questions lack answers establishing a product brand, oral formulation or approval status

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

Evernow: how care worksChecked 2026-09-29

Provider one-time versus membership access;90-day platform access not medication quantity, starting membership price not medicine price

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

Winona: Progesterone CapsulesChecked 2026-09-29

Provider oral-product listing; peanut oil and gelatin declared, starting price and broad cream-equivalence claims separated, no actual manufacturer or shipment authenticated

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

Winona: Estrogen Body Cream with ProgesteroneChecked 2026-09-29

Provider compounded estradiol/estriol/progesterone cream and starting price; uterine-protection and safety language attributed, not independently demonstrated

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

Winona: Frequently Asked QuestionsChecked 2026-09-29

Provider clinical and subscription conditions; age 35–59, listed jurisdictions, asynchronous care, differing approval descriptions, 28/84-day processing and 24-hour order window

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

British Menopause Society: Progestogens and Endometrial Protection (reviewed February 2026)Checked 2026-09-29

UK professional guidance internally reviewed February 2026, May 2026 file version; compounded transdermal progesterone evidence and absorption limitations, no claim of testing a reviewed brand

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

Gennev: virtual menopause careChecked 2026-09-29

Provider physician and dietitian service; actual relevant prescribing, but no exact oral progesterone product or capsule formulary established

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

Gennev: insurance and pricingChecked 2026-09-28

Dated provider fee table and coverage process; doctor/dietitian initial/follow-up costs are separate from pharmacy charges

Open the original document ↗

Checked 2026-09-28. Records and commercial terms may change.

MyMenopauseRx: treatmentsChecked 2026-09-29

Provider catalog naming progesterone and collective dosage forms; no inference that every hormone comes in every listed form

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

ACOG: Hormone Therapy for MenopauseChecked 2026-09-29

US specialty patient guidance; systemic and local exposure, treatment goals and clinical assessment, no personal regimen

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

MyMenopauseRx: telehealth FAQChecked 2026-09-28

Dated provider visit/pharmacy/refill/coverage/cancellation record; personal prescription, generic identity and clinical decisions remain unverified

Open the original document ↗

Checked 2026-09-28. Records and commercial terms may change.

Pandia Health: menopause hormone therapyChecked 2026-09-29

Provider therapy and capsule catalog; names progesterone and Prometrium, no selected stock or equivalence inference; public regimens not transferred

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

Pandia Health: menopause care and deliveryChecked 2026-09-28

Dated provider plans and prescription-transfer offer; separate medicine cost, billing units, 30-day notice and possible early fee, malformed three-month currency and inconsistent savings retained

Open the original document ↗

Checked 2026-09-28. Records and commercial terms may change.

Stella: US virtual menopause clinicChecked 2026-09-29

US provider clinical service and example plans; examples do not establish a universal oral preparation or individual outcome

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

Stella US: frequently asked questionsChecked 2026-09-28

Dated US provider age range, visit fees, pharmacy and coaching scope; no exact capsule ingredients, guaranteed reimbursement or UK offer inferred

Open the original document ↗

Checked 2026-09-28. Records and commercial terms may change.

Wisp: menopause consultationChecked 2026-09-28

Dated provider offer naming micronized progesterone and other oral options; starting care charge excludes local-pharmacy medicine, eligibility FAQ extraction incomplete

Open the original document ↗

Checked 2026-09-28. Records and commercial terms may change.

Pfizer Medical: Provera medroxyprogesterone acetateChecked 2026-09-29

Manufacturer medicine information; active-drug/tablet identity to distinguish Provera from micronized progesterone capsules, no dosing or study-result transfer

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

Wisp: terms of useChecked 2026-09-28

Dated platform transaction terms; prescription renewal review, 48-hour cancellation and discretionary product remedies; not individual legal advice

Open the original document ↗

Checked 2026-09-28. Records and commercial terms may change.

Thrivelab: Menopause hormone careChecked 2026-09-29

Provider clinical-service description; treatment and access wording is not an individual prescribing or state-eligibility confirmation

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

Thrivelab: Frequently asked questionsChecked 2026-09-29

Provider FAQ; separate membership, medication, state-access, laboratory and refund descriptions retain their stated limits

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

FDA: Understanding the Risks of Compounded DrugsChecked 2026-09-29

Federal primary guidance on compounding and lack of FDA premarket approval; not individual treatment advice

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

Thrivelab: Medication pricesChecked 2026-09-29

Provider medication tables dated April 5, 2024 and February 19, 2025; current page access does not update historical prices or explain formulation codes

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

FDA: Prometrium progesterone capsules prescribing informationChecked 2026-09-29

Exact FDA product label, reference ID 5744934; ingredients, indications and warnings apply to this product, not all progesterone preparations

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

Defy Medical: Menopause careChecked 2026-09-29

Provider menopause consultation and follow-up offer; no confirmed individual medicine, outcome or availability

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

Defy Medical: Hormone therapyChecked 2026-09-29

Provider treatment and route menu; oral hormone capsules do not establish a named progesterone formulation

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

Defy Medical: How much does BHRT cost?Checked 2026-09-29

Provider illustrative monthly cost averages, not fixed monthly billing or a capsule quote

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

FDA: Generic Drugs — Questions & AnswersChecked 2026-09-29

FDA public generic-drug explanation, updated September 18, 2026; approved-generic requirements and qualified inactive-ingredient differences, not identification or substitution advice for a particular provider prescription

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

BodyLogicMD: MenopauseChecked 2026-09-29

Provider menopause service and attributed testing or outcome claims; not comparative clinical evidence

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

BodyLogicMD: Find a bioidentical hormone doctorChecked 2026-09-29

Provider network and access description; no individual provider availability or exact capsule confirmed

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

BodyLogicMD: PricingChecked 2026-09-29

Provider membership and member-pricing terms; membership does not include every test or treatment

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

Renew Youth: Menopause servicesChecked 2026-09-29

Provider menopause clinical program and entry laboratory offer; exact capsule and complete treatment cost unconfirmed

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

Renew Youth: The Calming Hormone Women NeedChecked 2026-09-29

Provider article dated March 24, 2026; broad benefit and no-side-effect statements are attributed and critically qualified, not endorsed

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

British Menopause Society: Progestogens and endometrial protectionChecked 2026-09-29

UK professional clinical tool, internally reviewed February 2026; May 2026 is the URL/file version, not the stated review month. Preparation-specific evidence and endometrial-protection limits, with no dose or schedule instructions reproduced

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

Hone Health: Premium Membership, Full Clinical Insight for WomenChecked 2026-09-29

Provider Premium membership, separate estimated medicine menu and purchase conditions; compounded oral capsule listing is not an approved-product identity

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

Hone Health: Menopause treatmentChecked 2026-09-29

Provider menopause service, treatment goals and promotional timeline; not an individual outcome prediction

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

Hone Health: Progesterone Capsule for Women, Risks and BenefitsChecked 2026-09-29

Provider capsule benefit claims, including an unqualified cancer-prevention statement; reviewed as marketing and limited with exact FDA label context

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

Lifeforce: Micronized ProgesteroneChecked 2026-09-29

Provider product description, soy/peanut allergy notice and access terms; exact oral capsule, manufacturer and complete excipients not established

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

Lifeforce: Menopause ManagementChecked 2026-09-29

Provider menopause service and plan descriptions; different membership and testing statements remain unreconciled

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

Lifeforce: Become a memberChecked 2026-09-29

Provider recurring membership services and support roles; not a personal testing schedule or capsule price

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

Fountain: Hormone therapy for womenChecked 2026-09-29

Provider clinical service and kit; full four-, twelve- and forty-eight-week billing periods retained, exact capsule unconfirmed

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

Fountain: Terms and conditionsChecked 2026-09-29

Provider terms dated April 3, 2024; medical-group, prescription and pharmacy-choice clauses, not individual coverage or refund confirmation

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

Alpha Hormones: Bioidentical hormone replacement therapyChecked 2026-09-29

Provider treatment menu naming FDA-approved oral micronized progesterone and separately compounded options; no exact prescribed product confirmed

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

Alpha Hormones: PricingChecked 2026-09-29

Provider program starting prices, setup fee, access and insurance descriptions; individual selection and benefits remain unverified

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

Alpha Hormones: Subscription cancellation policyChecked 2026-09-29

Provider recurring billing, refill-request and cancellation/return conditions; attributed purchase policy, not generalized legal advice

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

Newson Clinic: ConsultationsChecked 2026-09-29

UK clinical assessment service; no exact oral medicine, individual eligibility or later NHS prescribing agreement confirmed

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

Newson Clinic: Menopause care and appointment pricesChecked 2026-09-29

UK provider service, locations and clinician-specific initial/follow-up price cards; appointment fees are not medicine prices

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

Besins Healthcare UK: Utrogestan 100 mg Capsules, SmPCChecked 2026-09-29

Manufacturer UK product information hosted by emc, last updated March 19, 2025; exact oral product indication and soya/peanut contraindication, not Newson availability

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

NHS: About Utrogestan, micronised progesteroneChecked 2026-09-29

UK public health medicine information, last reviewed January 5, 2023; oral HRT and vaginal fertility forms are distinguished, not interchangeable instructions

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

Duke Health — Menopause TreatmentChecked 2026-09-29

Official health-system clinical service, appointment or location page; exact product, personal access and full cost remain unconfirmed.

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

Duke Women’s Health Associates at Patterson PlaceChecked 2026-09-29

Official health-system clinical service, appointment or location page; exact product, personal access and full cost remain unconfirmed.

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

Cleveland Clinic — Menopause TreatmentChecked 2026-09-29

Official health-system clinical service, appointment or location page; exact product, personal access and full cost remain unconfirmed.

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

Cleveland Clinic — Specialized Women’s Health and MenopauseChecked 2026-09-29

Official health-system clinical service, appointment or location page; exact product, personal access and full cost remain unconfirmed.

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

Mayo Clinic — Menopause and Women’s Sexual Health Clinic in MinnesotaChecked 2026-09-29

Official health-system clinical service, appointment or location page; exact product, personal access and full cost remain unconfirmed.

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

Mayo Clinic — Women’s Health Specialty Clinic in FloridaChecked 2026-09-29

Official health-system clinical service, appointment or location page; exact product, personal access and full cost remain unconfirmed.

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

Johns Hopkins Medicine — Center for Menopause and Midlife HealthChecked 2026-09-29

Official health-system clinical service, appointment or location page; exact product, personal access and full cost remain unconfirmed.

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

Johns Hopkins Medicine — Menopause ClinicChecked 2026-09-29

Official health-system clinical service, appointment or location page; exact product, personal access and full cost remain unconfirmed.

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

Mount Sinai — Menopause Care and TreatmentsChecked 2026-09-29

Official health-system clinical service, appointment or location page; exact product, personal access and full cost remain unconfirmed.

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

Mount Sinai — Menopause Treatment LocationsChecked 2026-09-29

Official health-system clinical service, appointment or location page; exact product, personal access and full cost remain unconfirmed.

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

Northwestern Medicine — Program for MenopauseChecked 2026-09-29

Official health-system clinical service, appointment or location page; exact product, personal access and full cost remain unconfirmed.

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

Northwestern Medicine — Center for Sexual Medicine and Menopause, ChicagoChecked 2026-09-29

Official health-system clinical service, appointment or location page; exact product, personal access and full cost remain unconfirmed.

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

UCLA Health — Comprehensive Menopause Program: Clinical ServicesChecked 2026-09-29

Official health-system clinical service, appointment or location page; exact product, personal access and full cost remain unconfirmed.

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

UCLA Health — Comprehensive Menopause Program: Patient InformationChecked 2026-09-29

Official health-system clinical service, appointment or location page; exact product, personal access and full cost remain unconfirmed.

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

Stanford Health Care — MenopauseChecked 2026-09-29

Official health-system clinical service, appointment or location page; exact product, personal access and full cost remain unconfirmed.

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

Stanford Health Care — Menopause TreatmentsChecked 2026-09-29

Official health-system clinical service, appointment or location page; exact product, personal access and full cost remain unconfirmed.

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

University of Utah Health — Midlife Women’s Health and Menopause ProgramChecked 2026-09-29

Official health-system clinical service, appointment or location page; exact product, personal access and full cost remain unconfirmed.

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

University of Utah Health — What to Expect at Your Midlife AppointmentChecked 2026-09-29

Official health-system clinical service, appointment or location page; exact product, personal access and full cost remain unconfirmed.

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

DailyMed — PROMETRIUM progesterone capsule, Acertis Pharmaceuticals LLCChecked 2026-10-21

Exact identified oral product labeling, updated July 23, 2026; text only, no package-image inspection. Ingredient, formulation and WHI study details are not assigned to a health-system prescription.

Open the original document ↗

Checked 2026-10-21. Records and commercial terms may change.

FDA — Understanding the Risks of Compounded DrugsChecked 2026-09-29

Federal primary explanation of absent FDA approval and premarket review, with risk-based oversight; not a claim that compounding is wholly unregulated or that any clinic uses it.

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

FDA — Generic Drug FactsChecked 2026-09-29

Federal primary requirements for approved generic drugs; not compounding evidence or confirmation that all inactive ingredients match.

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

FDA — Understanding Unapproved Use of Approved Drugs: Off LabelChecked 2026-09-29

Federal explanation of unapproved use of an approved drug; no assertion of a particular clinic’s progesterone protocol or permission for self-directed changes.

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

ACOG — Hormone Therapy for MenopauseChecked 2026-09-29

Professional patient FAQ, last reviewed February 2024; used for the distinction between approved and compounded bioidentical options, not a current all-product label summary or provider protocol.

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

FDA — Hormone Replacement Therapies Can Help Women with Bothersome Menopausal SymptomsChecked 2026-09-29

Federal primary therapy-category explanation. Active ingredients remain distinct; requested labeling changes do not establish removal of every warning or identify a clinic product.

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

Mount Sinai — What Can I Do About My Menopause Symptoms?Checked 2026-09-29

Institutional educational interview dated May 26, 2021; used only for the documented progesterone term and unspecified formulation. Broad benefit and age statements are not adopted as current product evidence.

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

UCLA Health — Considering menopausal hormone therapy?Checked 2026-09-29

Institutional education dated December 18, 2025; used for its approval and identity terminology, not a formulary. Broad route-equivalence, low-dose and compounding-regulation claims are not adopted.

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

University of Utah Health — PostmenopauseChecked 2026-09-29

Institutional patient education distinguishing conventional and compounded bioidentical options. Does not identify the clinic’s product; broad preventive-benefit or regulation wording is not adopted.

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

Johns Hopkins Medicine — Introduction to MenopauseChecked 2026-09-29

Official Hopkins educational page retrieved via web after TinyFish bot blocking; tool reported crawled today. Bioidentical wording is examined rather than adopted as a regulatory definition; service evidence is separately registered.

Open the original document ↗

Checked 2026-09-29. Records and commercial terms may change.

CoreAge Rx: shipping reference and service detailsChecked 2026-10-12

Homepage shipping reference; customer service and payment details supplied for this review, without a checkout or timed support test

Open the original document ↗

Checked 2026-10-12. Records and commercial terms may change.

Oral micronized progesterone for vasomotor symptoms--a placebo-controlled randomized trial in healthy postmenopausal women.Checked 2026-10-21

Indexed primary study abstract

Open the original document ↗

Checked 2026-10-21. Records and commercial terms may change.

Oral micronized progesterone for perimenopausal night sweats and hot flushes a Phase III Canada-wide randomized placebo-controlled 4 month trial.Checked 2026-10-21

Indexed primary study abstract and full research article

Open the original document ↗

Checked 2026-10-21. Records and commercial terms may change.